Only logged in users can watch the content

Chat keyboard_arrow_down
Description keyboard_arrow_down

Click here to view the whole presentation

ESCP were delighted to host a joint session with EHTG (European Hereditary Tumour Group) on hereditary colorectal cancer. Part of this session saw Matthias Kloor present on ‘SI, HNPCC, Lynch syndrome and immunotherapy including vaccine: an update’


Faculty keyboard_arrow_down
Dr. Matthias Kloor Deputy Medical Director Applied Tumor Biology at Heidelberg University Hospital Surgical Oncology
Related Content keyboard_arrow_down